This is an outdated version published on 01/27/2022. Read the most recent version.
Role of Probiotic as an Add-on Therapy in Eradicating Helicobacter Pylori Infection
DOI:
https://doi.org/10.21649/akemu.v27i4.4890Keywords:
Helicobacter Pylori, Probiotic, Standard Triple Regimen.Abstract
Background: To compare the Helicobacter pylori eradication rate with and without use of Probiotic in conjunction with standard triple regimen. Methods: The patients with symptomatology of Gastritis and Dyspepsia were enrolled for the study. The presence of Helicobacter pylori was confirmed with Urea breath test. The experimental group received probiotic along with triple regimen therapy, while the control group received only triple regimen therapy. After four weeks of completion of treatment, urea breath test was repeated for confirmation of Helicobacter pylori eradication. Patients with negative urea breath test were considered as treatment success. Results: Total 160 patients with Helicobacter pylori infection were enrolled in this study. Patients were divided in two groups i.e. Group-A (Probiotic + triple regimen therapy) and Group-B (Only triple regimen therapy). The mean age of patients in group-A was 35.1±11.2 years and in group-B 37.5±12.9 years. In group-A, H. pylori eradication was seen in 71(88.8%) and 59(73.8%) in group-B with a p-value of 0.015 which is statistically significant. Conclusion: In Helicobacter pylori confirmed Gastritis or Dyspepsia patients, addition of probiotic to standard triple regimen therapy improve eradication rate of H. pylori infection.Downloads
Published
01/27/2022
Versions
- 02/02/2022 (2)
- 01/27/2022 (1)
How to Cite
Role of Probiotic as an Add-on Therapy in Eradicating Helicobacter Pylori Infection. (2022). Annals of King Edward Medical University, 27(4), 558–563. https://doi.org/10.21649/akemu.v27i4.4890
Issue
Section
Research Articles
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk